Pyrimidine Synthesis Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Pyrimidine Synthesis Inhibitor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209555-001 | May 15, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209710-001 | Jan 3, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alembic | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209572-001 | Apr 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Apotex | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209601-001 | Nov 2, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |